Research Article

The Impact of Comorbidities on the Outcomes of Egyptian COVID-19 Patients: A Follow-Up Study

Table 3

Multilinear logistic regression to detect predictors that cause death to COVID-19 patients.

B valueLower limit of 95% CIUpper limit of 95% CI

Comorbidity presence (Group II is reference)36.27<0.0012.533.14
History of fever−1.40.19−3.5114.2
Headache−3.370.080.096.45
Cough−3.100.082−11.432.15
SOB22.430.0049.5513.64
Nasal congestion4.060.0740.0121.87
Fatigue4.110.07−3.61.22
Cyanosis23.180.0010.0340.39

Significant at . CI: confidence interval.